Search Results

Filter
  • 1-10 of  120,739 results for ""CYCLOSPORINE""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Reference

Cyclosporine

  • Source: Funk & Wagnalls New World Encyclopedia. 2018, 1p.

Record details

×
Academic Journal

Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial.

  • Authors : Ruggenenti P; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.; Unit of Nephrology and Dialysis, ASST Papa Giovanni XXIII, Bergamo, Italy.

Subjects: Kidney Transplantation*/Kidney Transplantation*/Kidney Transplantation*/adverse effects; Azathioprine/Azathioprine/Azathioprine/*administration & dosage ; Cyclosporine/Cyclosporine/Cyclosporine/*administration & dosage

  • Source: PLoS medicine [PLoS Med] 2021 Jun 24; Vol. 18 (6), pp. e1003668. Date of Electronic Publication: 2021 Jun 24 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Development of a Population Pharmacokinetic Model for Cyclosporine from Therapeutic Drug Monitoring Data.

  • Authors : Umpiérrez M; Pharmaceutical Sciences Department, Faculty of Chemistry, Universidad de la República, Uruguay, General Flores, 2124 Montevideo, Uruguay.; Guevara N

Subjects: Drug Monitoring* ; Models, Biological*; Cyclosporine/Cyclosporine/Cyclosporine/*pharmacokinetics

  • Source: BioMed research international [Biomed Res Int] 2021 Apr 08; Vol. 2021, pp. 3108749. Date of Electronic Publication: 2021 Apr 08 (Print Publication: 2021).Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Safety and efficacy of methotrexate (0.3 mg/kg/week) versus a combination of methotrexate (0.15 mg/kg/week) with cyclosporine (2.5 mg/kg/day) in chronic plaque psoriasis: A randomised non-blinded controlled trial.

  • Authors : Singh SK; Department of Dermatology and Venereology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.; Singnarpi SR

Subjects: Cyclosporine/Cyclosporine/Cyclosporine/*administration & dosage ; Dermatologic Agents/Dermatologic Agents/Dermatologic Agents/*administration & dosage ; Methotrexate/Methotrexate/Methotrexate/*administration & dosage

  • Source: Indian journal of dermatology, venereology and leprology [Indian J Dermatol Venereol Leprol] 2021 Mar-Apr; Vol. 87 (2), pp. 214-222.Publisher: Scientific Scholar on behalf of Indian Association of Dermatologists, Venereologists & Leprologists Country of Publication: United States NLM ID: 7701852

Record details

×
Review

Three toxic epidermal necrolysis cases treated with cyclosporine and a review of the literature.

  • Authors : Bozca BC; Department of Dermatology and Venerology, Akdeniz University School of Medicine, Antalya, Turkey.; Irican CM

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/adverse effects ; Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/diagnosis ; Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/drug therapy

  • Source: Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e14435. Date of Electronic Publication: 2020 Oct 29.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Report

Successful use of cyclosporine in epidermolysis bullosa pruriginosa.

  • Authors : Kaushik A; Department of Dermatology, Venereology and Leprology, PGIMER, Chandigarh, India.; Mahajan R

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use ; Epidermolysis Bullosa*/Epidermolysis Bullosa*/Epidermolysis Bullosa*/diagnosis ; Epidermolysis Bullosa*/Epidermolysis Bullosa*/Epidermolysis Bullosa*/drug therapy Epidermolysis Bullosa Pruriginosa

  • Source: Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e14489. Date of Electronic Publication: 2020 Nov 10.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Report

Efficacy of cyclosporine treatment on severe recalcitrant nodular vasculitis.

  • Authors : Ye R; Institute of Dermatology, Guangzhou Medical University, Guangzhou, Guangdong, China.; Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, Guangdong, China.

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use ; Vasculitis*; Humans

  • Source: Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e13870. Date of Electronic Publication: 2020 Aug 18.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Treatment with the calcineurin inhibitor and immunosuppressant cyclosporine A impairs sensorimotor gating in Dark Agouti rats.

  • Authors : Brosda J; Institute of Pharmacology and Toxicology, School of Veterinary Medicine, Freie Universität Berlin, 14195, Berlin, Germany.; Becker T

Subjects: Calcineurin Inhibitors/Calcineurin Inhibitors/Calcineurin Inhibitors/*pharmacology ; Cyclosporine/Cyclosporine/Cyclosporine/*pharmacology ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*pharmacology

  • Source: Psychopharmacology [Psychopharmacology (Berl)] 2021 Apr; Vol. 238 (4), pp. 1047-1057. Date of Electronic Publication: 2020 Dec 21.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

In vitro and in vivo amelioration of colitis using targeted delivery system of cyclosporine a in New Zealand rabbits.

  • Authors : Sharma S; University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India.; Sinha VR

Subjects: Colitis*/Colitis*/Colitis*/chemically induced ; Colitis*/Colitis*/Colitis*/drug therapy ; Cyclosporine*

  • Source: Drug development and industrial pharmacy [Drug Dev Ind Pharm] 2020 Oct; Vol. 46 (10), pp. 1726-1733. Date of Electronic Publication: 2020 Sep 21.Publisher: Informa Healthcare Country of Publication: England NLM ID: 7802620 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

More about the combination of rituximab, cyclosporine and dexamethasone in the treatment of chronic ITP. A useful option on an environment with limited resources.

  • Authors : Thabet AF; Department of Internal Medicine, Clinical Hematology Unit, Faculty of Medicine, Assiut University , Assiut, Egypt.; Moeen SM

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Cyclosporine/Cyclosporine/Cyclosporine/*therapeutic use ; Dexamethasone/Dexamethasone/Dexamethasone/*therapeutic use

  • Source: Platelets [Platelets] 2020 Aug 17; Vol. 31 (6), pp. 784-787. Date of Electronic Publication: 2019 Oct 11.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9208117 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  120,739 results for ""CYCLOSPORINE""